Literature DB >> 8946611

Colorectal cancer in idiopathic inflammatory bowel disease.

N Harpaz1, I C Talbot.   

Abstract

The development of colorectal cancer is the most serious long-term problem faced by patients with extensive ulcerative colitis and Crohn's colitis, with an incidence 20-fold higher and an average age of onset 20 years younger than colorectal cancer in the general population. This report summarizes the epidemiology, pathology, and recent advances in the molecular pathogenesis of colorectal cancer in inflammatory bowel disease and of its acknowledged precursor, mucosal dysplasia. It also reviews the rationale behind the use of endoscopic surveillance for dysplasia as a means of reducing cancer mortality, as well as some of the issues involved in its effective implementation.

Entities:  

Mesh:

Year:  1996        PMID: 8946611

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  19 in total

Review 1.  DNA methylation changes in gastrointestinal disease.

Authors:  Minoru Toyota; Fumio Itoh; Takefumi Kikuchi; Ayumi Satoh; Toshiro Obata; Hiromu Suzuki; Suguru Ishii; Takao Endo; Takashi Tokino; Kohzoh Imai
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 2.  Radical induction theory of ulcerative colitis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

3.  Role for epithelial dysregulation in early-onset colitis-associated colon cancer in Gi2-alpha-/- mice.

Authors:  Robert A Edwards; Kehui Wang; Jennifer S Davis; Lutz Birnbaumer
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

Review 4.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

5.  Colorectal cancer in inflammatory bowel disease.

Authors:  Jonathan Potack; Steven H Itzkowitz
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

6.  Chromoendoscopy and Dysplasia Surveillance in Inflammatory Bowel Disease: Past, Present, and Future.

Authors:  Steven Naymagon; Thomas A Ullman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-05

7.  Aneuploidy-associated gene expression signatures characterize malignant transformation in ulcerative colitis.

Authors:  Marco Gerling; Kari Nousiainen; Sampsa Hautaniemi; Stefan Krüger; Britta Fritzsche; Nils Homann; Hans-Peter Bruch; Gert Auer; Uwe J Roblick; Thomas Ried; Jens K Habermann
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

Review 8.  Cancer in inflammatory bowel disease.

Authors:  Jianlin Xie; Steven H Itzkowitz
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Stability and reactivity of 2-nitrosoamino-3,8-dimethylimidazo[4,5-f]quinoxaline.

Authors:  Vijaya M Lakshmi; Fong Fu Hsu; Herman A J Schut; Terry V Zenser
Journal:  Chem Res Toxicol       Date:  2006-02       Impact factor: 3.739

10.  Proctocolectomy for colon cancer associated with ulcerative colitis a few months after living donor liver transplantation for primary sclerosing cholangitis: report of a case.

Authors:  Takasuke Fukuhara; Akinori Egashira; Masakazu Imamura; Toru Ikegami; Eiji Oki; Yuji Soejima; Noriaki Sadanaga; Akinobu Taketomi; Takashi Yao; Masaru Morita; Yoshihiro Kakeji; Masazumi Tsuneyoshi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.